Tech News
← Back to articles

BioMarin to Buy Rare-Disease Biotech Amicus Therapeutics for $4.8 Billion

2025-12-19 | original
read original related products more articles

BioMarin Pharmaceutical has struck a deal to buy fellow biotechnology company Amicus Therapeutics for about $4.8 billion in cash.

Related:
OpenAI is reportedly trying to raise $100B at an $830B valuation
North Korean hackers stole record $2 billion in crypto in 2025, including single heist worth $1.5 billion, report claims — rogue state accounts for 60% of all reported crypto thefts this year, $6.75 billion total since records began
Data center deals hit record $61 billion in 2025 amid construction frenzy
Trump's Social Media Business Is Merging With a Nuclear Fusion Company
BTC price update: Bitcoin, crypto market could plummet again on ‘Witching Friday.’ Here’s why

© 2025 GoKawiil